Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome ; day:26 ; month:11 ; year:2024 ; pages:1-12
Annals of hematology ; (26.11.2024), 1-12
- Urheber
-
Abdelfattah, Nesma E.
Elsayed, Ghada M.
Soliman, Amira H.
Ebeid, Emad N.
El Ashry, Mona S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-024-06102-2
- URN
-
urn:nbn:de:101:1-2502112117448.087569331729
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abdelfattah, Nesma E.
- Elsayed, Ghada M.
- Soliman, Amira H.
- Ebeid, Emad N.
- El Ashry, Mona S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia
Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: a case report
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France
Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia
Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: a case report
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France
Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia
Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: a case report
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France
Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions